Consequences of COVID-19 for cancer care - a CRUK perspective

Emma Greenwood; Charles Swanton

doi:10.1038/s41571-020-00446-0

Consequences of COVID-19 for cancer care - a CRUK perspective

Nat Rev Clin Oncol. 2021 Jan;18(1):3-4. doi: 10.1038/s41571-020-00446-0.

Authors

Emma Greenwood¹, Charles Swanton^{2

3

4}

Affiliations

¹ Cancer Research UK, Redman Place, London, UK.
² Cancer Research UK, Redman Place, London, UK. Charles.Swanton@crick.ac.uk.
³ Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.
⁴ Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.Swanton@crick.ac.uk.

Abstract

We reflect on the past 10 months of clinical activity in oncology in the UK during the COVID-19 pandemic and suggest how services can be protected during subsequent waves of infection.

MeSH terms

Biomedical Research / methods
Biomedical Research / statistics & numerical data*
Biomedical Research / trends
COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 / virology
Epidemics
Humans
Medical Oncology / methods
Medical Oncology / statistics & numerical data*
Medical Oncology / trends
Neoplasms / diagnosis
Neoplasms / therapy*
SARS-CoV-2 / isolation & purification*
SARS-CoV-2 / physiology
United Kingdom